Tag Archive for: exit

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

Deal value up to US$1.05 billion Novo Holdings co-led Series A financing in Amolyt, supported additional financings and is Amolyt’s largest investor Acquisition validates Novo Holdings’ strategy to identify and invest long term in high quality European biotech companies Copenhagen, Denmark – Novo Holdings A/S, a leading international life sciences investor, today announced that its portfolio […]